Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Amgen, Inc. (AMGN) vs Endeavour Silver Corp (EXK) Price & Performance

Amgen, Inc.Trade
Endeavour Silver CorpTrade

Price performance (Past 24H)

Key statistics

Amgen, Inc. vs Endeavour Silver Corp — how do they compare? Amgen, Inc. trades at $412.21 (market cap $224.14B), while Endeavour Silver Corp trades at $10.9 (market cap $3.14B). The key difference: Amgen, Inc. is far larger — about 71.4× Endeavour Silver Corp's market cap, and Amgen, Inc. pays a 2.43% dividend while Endeavour Silver Corp pays none. Which is the better fit depends on your goals.

AMGNEXK
Market Cap
$224.14B$3.14B
Sector
HealthBasic Materials
52-Week High
$417.20$14.12
52-Week Low
$271.18$5.31
Enterprise Value
$267.45B$3.14B
Dividend Yield
2.43%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Amgen, Inc.

Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). Amgen's biosimilar portfolio includes Mvasi (biosimilar Avastin), Kanjinti (biosimilar Herceptin), and Amgevita (biosimilar Humira).

Read more on AMGN

About Endeavour Silver Corp

Endeavour Silver is a mid-tier precious metals mining company. It operates silver-gold mines in Mexico and is focused on growing its production and reserves through exploration and the development of new mining projects.

Read more on EXK